SEC Form 4 · accession 0000950142-26-002522
Medicus Pharma Ltd. · MDCX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Alasdair Smith
Officer — Chief Operating Officer
Period of report
Sep 4, 2026
Accepted (ET)
Sep 8, 2026 · 5:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001997296
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value | Sep 4, 2026 | A | 735,294 | $0.1705 | A | 735,458 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.1705 | Sep 4, 2026 | A | 125,000 | A | — | Sep 4, 2031 | Common Shares | 125,000 | 125,000 | D |
Explanation of responses
- F1The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year.